2m 2m 2m 2m 2m 2m 2m
APREA THERAPEUT (APRE)
NASDAQ
$0.62-$0.004 (-0.65%)
Price as of Aug 03, 2026 7:35 AM EDT- $7.7MMarket Cap
- -62.65%1-Year Change
- BiotechnologyIndustry
APREA THERAPEUT (APRE)
$0.62-$0.004 (-0.65%)
APRE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.62 | ||
Change | -$0.01 (-2.36%) | ||
Open | $0.64 | ||
High | $0.66 | ||
Low | $0.61 | ||
Previous Close | $0.64 | ||
Volume | 50,906 | ||
30-Day Average Volume | 60,783 | ||
1-Week Change | -1.90% | ||
1-Month Change | -22.72% | ||
1-Year Change | -62.65% | ||
3-Year Change | -80.00% | ||
5-Year Change | -99.27% | ||
Fundamentals | |||
Shares Outstanding | 12.4M | ||
Total Assets | $47.6M | ||
Market Cap | $7.7M | ||
Enterprise Value | -$38.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$3.3M | ||
Free Cash Flow | -$2.8M | ||
EBIT | -$3.3M | ||
EBITDA | -$3.3M | ||
Net Working Capital | $41.9M | ||
EPS | -$0.22 | ||
Enterprise Value/EBITDA | 12 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -3 | ||
PEG | -0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 02/13/2023 | ||
Earnings & Revenue